|
1
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar
|
|
2
|
Voloshanenko O, Erdmann G, Dubash TD,
Augustin I, Metzig M, Moffa G, Hundsrucker C, Kerr G, Sandmann T,
Anchang B, et al: Wnt secretion is required to maintain high levels
of Wnt activity in colon cancer cells. Nat Commun. 4:26102013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang W, Xu L, Liu P, Jairam K, Yin Y, Chen
K, Sprengers D, Peppelenbosch MP, Pan Q and Smits R: Blocking wnt
secretion reduces growth of hepatocellular carcinoma cell lines
mostly independent of β-catenin signaling. Neoplasia. 18:711–723.
2016. View Article : Google Scholar
|
|
4
|
Cleary AS, Leonard TL, Gestl SA and
Gunther EJ: Tumour cell heterogeneity maintained by cooperating
subclones in Wnt-driven mammary cancers. Nature. 508:113–117. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Behrens J, Von Kries JP, Kühl M, Bruhn L,
Wedlich D, Grosschedl R and Birchmeier W: Functional interaction of
beta-catenin with the transcription factor LEF- 1. Nature.
382:638–642. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
He TC, Sparks AB, Rago C, Hermeking H,
Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW:
Identification of c-MYC as a target of the APC pathway. Science.
281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tetsu O and McCormick F: Beta-catenin
regulates expression of cyclin D1 in colon carcinoma cells. Nature.
398:422–426. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Frietze S, Wang R, Yao L, Tak YG, Ye Z,
Gaddis M, Witt H, Farnham PJ and Jin VX: Cell type-specific binding
patterns reveal that TCF7L2 can be tethered to the genome by
association with GATA3. Genome Biol. 13:R522012. View Article : Google Scholar
|
|
9
|
Zhu C, Yamaguchi K, Ohsugi T, Terakado Y,
Noguchi R, Ikenoue T and Furukawa Y: Identification of FERM
domain-containing protein 5 as a novel target of β-catenin/TCF7L2
complex. Cancer Sci. 108:612–619. 2017. View Article : Google Scholar
|
|
10
|
Fujita M, Furukawa Y, Tsunoda T, Tanaka T,
Ogawa M and Nakamura Y: Up-regulation of the ectodermal-neural
cortex 1 (ENC1) gene, a downstream target of the β-catenin/T-cell
factor complex, in colorectal carcinomas. Cancer Res. 61:7722–7726.
2001.PubMed/NCBI
|
|
11
|
Miwa N, Furuse M, Tsukita S, Niikawa N,
Nakamura Y and Furukawa Y: Involvement of claudin-1 in the
beta-catenin/Tcf signaling pathway and its frequent upregulation in
human colorectal cancers. Oncol Res. 12:469–476. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takahashi M, Tsunoda T, Seiki M, Nakamura
Y and Furukawa Y: Identification of membrane-type matrix
metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in
human colorectal cancers. Oncogene. 21:5861–5867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamaguchi K, Zhu C, Ohsugi T, Yamaguchi Y,
Ikenoue T and Furukawa Y: Bidirectional reporter assay using HAL
promoter and TOPFLASH improves specificity in high-throughput
screening of Wnt inhibitors. Biotechnol Bioeng. 114:2868–2882.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sandelin A, Alkema W, Engström P,
Wasserman WW and Lenhard B: JASPAR: An open-access database for
eukaryotic transcription factor binding profiles. Nucleic Acids
Res. 32:D91–D94. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamaguchi K, Yamaguchi R, Takahashi N,
Ikenoue T, Fujii T, Shinozaki M, Tsurita G, Hata K, Niida A, Imoto
S, et al: Overexpression of cohesion establishment factor DSCC1
through E2F in colorectal cancer. PLoS One. 9:e857502014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hagege H, Klous P, Braem C, Splinter E,
Dekker J, Cathala G, de Laat W and Forné T: Quantitative analysis
of chromosome conformation capture assays (3C-qPCR). Nat Protoc.
2:1722–1733. 2007. View Article : Google Scholar
|
|
17
|
Tsukamoto S, Ishikawa T, Iida S, Ishiguro
M, Mogushi K, Mizushima H, Uetake H, Tanaka H and Sugihara K:
Clinical significance of osteoprotegerin expression in human
colorectal cancer. Clin Cancer Clin. 17:2444–2450. 2011. View Article : Google Scholar
|
|
18
|
Schatoff EM, Leach BI and Dow LE: Wnt
Signaling and colorectal cancer. Curr Colorectal Cancer Rep.
13:101–110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takahashi N, Yamaguchi K, Ikenoue T, Fujii
T and Furukawa Y: Identification of two Wnt-responsive elements in
the intron of RING finger protein 43 (RNF43) Gene. PLoS One.
9:e865822014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Thaler R, Rumpler M, Spitzer S, Klaushofer
K and Varga F: Mospd1, a new player in mesenchymal versus epidermal
cell differentiation. J Cell Physiol. 226:2505–2515. 2011.
View Article : Google Scholar
|
|
21
|
Klass MR and Hirsh D: Sperm isolation and
biochemical analysis of the major sperm protein from caenorhabditis
elegans. Dev Biol. 84:299–312. 1981. View Article : Google Scholar
|
|
22
|
Sepsenwol S, Ris H and Roberts TM: A
unique cytoskeleton associated with crawling in the amoeboid sperm
of the nematode, Ascaris suum. J Cell Biol. 108:55–66. 1989.
View Article : Google Scholar
|
|
23
|
Nelson GA, Roberts TM and Ward S:
Caenorhabditis elegans spermatozoan locomotion: Amoeboid movement
with almost no actin. J Cell Biol. 92:121–131. 1982. View Article : Google Scholar
|
|
24
|
Kara M, Axton RA, Jackson M, Ghaffari S,
Buerger K, Watt AJ, Taylor AH, Orr B, Hardy WR, Peault B and
Forrester LM: A role for MOSPD1 in mesenchymal stem cell
proliferation and differentiation. Stem Cells. 33:3077–3086. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Puiffe ML, Le Page C, Filali-Mouhim A,
Zietarska M, Ouellet V, Tonin PN, Chevrette M, Provencher DM and
Mes-Masson AM: Characterization of ovarian cancer ascites on cell
invasion, proliferation, spheroid formation, and gene expression in
an in vitro model of epithelial ovarian cancer. Neoplasia.
9:820–829. 2007. View Article : Google Scholar
|
|
26
|
Puisieux A, Brabletz T and Caramel J:
Oncogenic roles of EMT–inducing transcription factors. Nat Cell
Biol. 16:488–494. 2014. View Article : Google Scholar
|
|
27
|
Dancer JY, Henry SP, Bondaruk J, Lee S,
Ayala AG, de Crombrugghe B and Czerniak B: Expression of master
regulatory genes controlling skeletal development in benign
cartilage and bone forming tumors. Hum Pathol. 41:1788–1793. 2010.
View Article : Google Scholar
|
|
28
|
Groen EJ, Roos A, Muntinghe FL, Enting RH,
de Vries J, Kleibeuker JH, Witjes MJH, Links TP and van Beek AP:
Extra-intestinal manifestations of familial adenomatous polyposis.
Ann Surg Oncol. 15:2439–2450. 2008. View Article : Google Scholar
|
|
29
|
Takahashi M, Nakamura Y, Obama K and
Furukawa Y: Identification of SP5 as a downstream gene of the
beta-catenin/Tcf pathway and its enhanced expression in human colon
cancer. Int J Oncol. 27:1483–1487. 2005.
|
|
30
|
Jho EH, Zhang T, Domon C, Joo CK, Freund
JN and Costantini F: Wnt/beta-catenin/Tcf signaling induces the
transcription of axin2, a negative regulator of the signaling
pathway. Mol Cell Biol. 22:1172–1183. 2002. View Article : Google Scholar
|
|
31
|
Yochum GS, Cleland R and Goodman RH: A
genome-wide screen for beta-catenin binding sites identifies a
downstream enhancer element that controls c -myc gene expression.
Mol Cell Biol. 28:7368–7379. 2008. View Article : Google Scholar
|
